A Tumor-on-a-chip Platform For Screening Precision Medicine-driven Therapies

被引：0
|
作者：
Forsythe, S. [1 ]
Mehta, N. [1 ]
Alistar, A. [2 ,3 ]
Hall, A. [1 ,3 ,4 ]
Skardal, A. [1 ,3 ,4 ]
机构：
[1] Wake Forest Baptist Med Ctr, Inst Regenerat Med, Winston Salem, NC USA
[2] Wake Forest Baptist Med Ctr, Hematol & Oncol, Winston Salem, NC USA
[3] Wake Forest Baptist Med Ctr, Ctr Comprehens Canc, Winston Salem, NC USA
[4] Wake Forest Baptist Med Ctr, Biomed Engn, Winston Salem, NC USA
来源：
TISSUE ENGINEERING PART A | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
129
引用
收藏
页码：S35 / S36
页数：2
相关论文
共 50 条
  • [31] ON-CHIP 3D CELL CULTURE PLATFORM FOR TUMOR MODELING AND DRUG SCREENING
    Yildirim, Ozum
    Yildiz, Ahu Arslan
    TISSUE ENGINEERING PART A, 2022, 28 : S544 - S544
  • [32] TOWARDS PRECISION MEDICINE: AUTOMATED DRUG SCREENING PLATFORM UTILIZING TUMOR-ORGANOIDS TO IDENTIFY PATIENT-SPECIFIC DRUG-RESPONSES IN MENINGIOMA
    Jungwirth, Gerhard
    Paul, Adrian
    Cao Junguo
    Unterberg, Andreas
    Abdollahi, Amir
    Herold-Mende, Christel
    NEURO-ONCOLOGY, 2021, 23 : 83 - 83
  • [33] Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
    Zhou, Zilong
    Cong, Lele
    Cong, Xianling
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [34] Bioprinted Organoids Platform with Tumor Vasculature for Implementing Precision Personalized Medicine Targeted Towards Gastric Cancer
    Kim, Jisoo
    Kim, Jungmin
    Gao, Ge
    Choi, Yoo-mi
    Kim, Jaewook
    Cho, Dong-Woo
    Cheong, Jae-Ho
    Jang, Jinah
    ADVANCED FUNCTIONAL MATERIALS, 2024, 34 (11)
  • [35] Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challenges
    Yuan Mao
    Dangang Shangguan
    Qi Huang
    Ling Xiao
    Dongsheng Cao
    Hui Zhou
    Yi-Kun Wang
    Molecular Cancer, 24 (1)
  • [36] Development of Nationwide Genomic Screening Platform (LC-SCRUM-Japan) to Establish Precision Medicine in Lung Cancer
    Goto, Koichi
    CANCER SCIENCE, 2018, 109 : 1224 - 1224
  • [37] Enabling a Paradigm Shift in Precision Medicine: Circulating Tumor Cell Isolation Platform Boosts Versatility in Molecular Analysis
    Mumford, Kyra
    Genetic Engineering and Biotechnology News, 2015, 35 (17):
  • [38] A patient-derived xenograft (PDX) platform to optimize omics-driven precision medicine in bladder cancer.
    Pan, Chong-xian
    Zhang, Hongyong
    Tepper, Clifford
    Ghosh, Paramita
    Kuslak-Meyer, Sheri
    Airhart, Susan D.
    Gandara, David R.
    Liu, Edison T.
    White, Ralph deVere
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] 3D bioprinted, vascularized neuroblastoma tumor environment in fluidic chip devices for precision medicine drug testing
    Nothdurfter, Daniel
    Ploner, Christian
    Coraca-Huber, Debora C.
    Wilflingseder, Doris
    Mueller, Thomas
    Hermann, Martin
    Hagenbuchner, Judith
    Ausserlechner, Michael J.
    BIOFABRICATION, 2022, 14 (03)
  • [40] TQuest, A Web-Based Platform to Enable Precision Medicine by Linking a Tumor's Genetic Defects to Therapeutic Options
    Gershkovich, Peter
    Platt, James
    Knopf, Joshua
    Tasoulis, Marios K.
    Shi, Weiwei
    Pusztai, Lajos
    Hatzis, Christos
    JCO CLINICAL CANCER INFORMATICS, 2018, 2 : 1 - 13
12345